论文部分内容阅读
美国亚特兰大消息:据美国胃肠病学会年会的报告称,治疗十二指肠溃疡的新药Famo-tidine似乎具有非常明显的疗效。该药药效强、药效持续时间长、有理想的安全范围。每天用药一次就似乎有效。加利福尼亚州Norman Gitlin医师说,在治愈溃疡的研究中,将病人分4组,每晚给40mgFamotidine的8名病人,83％在治疗8周时经内窥镜检查,溃疡愈合;每天二次,每次给药40mg的93名病人,溃疡治愈率为82％;每天二次,每次用药20mg的84名病人,溃疡治愈率为82％;安慰剂组的97名病人溃疡治愈率为45％。Gitl-in说,由于上述Famotidine三种治疗方案结果类似,每晚40mg的Famotidine被推荐为治疗剂量。此药能被“完全耐受”,“副作用很轻”。
Atlanta, United States: According to the report of the annual meeting of the American Gastroenterological Association, Famotidine, a new drug for the treatment of duodenal ulcer, appears to have a very significant effect. The drug efficacy, long duration of efficacy, the ideal range of safety. Once a day medication seems to be effective. According to Dr. Norman Gitlin of California, in the ulcer-healing study, patients were divided into 4 groups, 8 patients were given 40 mg Famotidine nightly and 83% were endoscopically treated for 8 weeks. Ulcers healed twice daily A total of 93 patients treated 40 mg twice a day had ulcer cure rates of 82%. Eighty-four patients with 20 mg twice daily had a cure rate of 82%. The cure rate for the 97 patients in the placebo group was 45%. Gitl-in said Famotidine 40 mg per night is recommended as a therapeutic dose because of similar results for the three Famotidine treatment options. This medicine can be “completely tolerated” with “very mild side effects.”